^
1d
Hybrid Dissolving Microneedles Incorporating Hyaluronic Acid Microdepots for Pain-free and Long-acting Corticosteroid Therapy. (PubMed, Biomater Res)
This study presents a long-acting hybrid dissolving microneedle (DMN) patch incorporating hyaluronic acid (HA)-based microparticle depots (TA@MDepots) for intradermal delivery of triamcinolone acetonide (TA)...Histological analyses confirm skin structure restoration and immune modulation, while systemic toxicity assessments show no adverse effects. This hybrid DMN platform offers a minimally invasive, biocompatible, and patient-friendly strategy for prolonged corticosteroid delivery in chronic inflammatory skin diseases and represents a promising alternative to conventional topical or injectable therapies.
Journal
|
IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha)
1d
Local Methotrexate Injections for the Treatment of Nail Psoriasis (clinicaltrials.gov)
P4, N=1, Terminated, Weill Medical College of Cornell University | Active, not recruiting --> Terminated; The study was terminated due to slow accrual.
Trial termination
2d
Efficacy of Dengue Infection With Warning Signs Treated With Dexamethasone (DengDex Study) (clinicaltrials.gov)
P=N/A, N=200, Recruiting, Chulalongkorn University | Trial completion date: Dec 2026 --> Dec 2027 | Trial primary completion date: Dec 2025 --> Nov 2026
Trial completion date • Trial primary completion date
|
dexamethasone
2d
New P3 trial
|
methylprednisolone acetate
2d
Clinical and immunological effects of adding cyclophosphamide to pomalidomide-dexamethasone in relapsed-refractory multiple myeloma: The randomized MUKseven trial. (PubMed, Br J Haematol)
Pretreatment CD4+ T-cell levels were identified as a prognostic PFS marker. In summary, our results demonstrate significant effects of cycloaddition to Pd on response and T-cell composition.
Journal
|
CD8 (cluster of differentiation 8) • CD4 (CD4 Molecule)
|
cyclophosphamide • dexamethasone • pomalidomide
3d
Stress-Induced Changes in the Methylation Status of Mmp1 and Mmp8 Genes in Tumor Tissue of Rats with Guerin Carcinoma. (PubMed, Exp Oncol)
Our study demonstrated that chronic glucocorticoid-induced stress altered the epigenetic profile of tumor cells by in- ducing differential methylation of the matrix metalloproteinase genes. Specifi  ally, it promoted the maintenance of Mmp1 hypomethylation and signifi  antly increased the Mmp8 promoter hypermethylation. These fi  dings suggest that chronic stress may contribute to an aggressive tumor phenotype through the epigenetic regulation of extracel- lular matrix remodeling.
Preclinical • Journal
|
MMP1 (Matrix metallopeptidase 1) • MMP8 (Matrix Metallopeptidase 8)
|
dexamethasone
6d
Paraneoplastic neurologic syndrome in advanced lung cancer with mixed adenocarcinoma and squamous features: a diagnostic challenge-a case report. (PubMed, J Med Case Rep)
This case highlights the diagnostic challenges of antibody-negative paraneoplastic neurologic syndromes. The study underscores the important role of PET-CT in identifying occult malignancy and the role of repeat biopsy in progressive disease. Discordant histologic findings should be interpreted cautiously, as they may reflect tumor heterogeneity or possible adenosquamous carcinoma rather than true histologic evolution. Limited molecular testing, and sampling constraints remain important challenges, particularly in resource-limited settings.
Journal
|
TTF1 (Transcription Termination Factor 1) • NKX2-1 (NK2 Homeobox 1) • TP63 (Tumor protein 63)
|
carboplatin • pemetrexed • methylprednisolone sodium succinate
7d
Enrollment closed
7d
Trial completion
|
dexamethasone injection
8d
ABCD: Dexamethasone in Controlling Dyspnea in Patients With Cancer (clinicaltrials.gov)
P2, N=135, Active, not recruiting, M.D. Anderson Cancer Center | Trial completion date: Dec 2025 --> Dec 2028
Trial completion date
8d
Enrollment open
|
dexamethasone injection
8d
New trial
|
dexamethasone injection